[
  {
    "ts": "2026-01-16T01:00:00+00:00",
    "headline": "Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs",
    "summary": "Antengene Corporation Limited (\"Antengene\", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that it recently presented at the 44th Annual J.P. Morgan Healthcare Conference held in San Francisco. At the conference, Antengene shared the latest data and clinical development plan",
    "url": "https://finance.yahoo.com/news/antengene-presents-jpm-strong-clinical-010000312.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "769b4637-23f1-3f69-a1b8-bd19936f7b28",
      "content": {
        "id": "769b4637-23f1-3f69-a1b8-bd19936f7b28",
        "contentType": "STORY",
        "title": "Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs",
        "description": "",
        "summary": "Antengene Corporation Limited (\"Antengene\", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that it recently presented at the 44th Annual J.P. Morgan Healthcare Conference held in San Francisco. At the conference, Antengene shared the latest data and clinical development plan",
        "pubDate": "2026-01-16T01:00:00Z",
        "displayTime": "2026-01-16T01:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/80e76465ee715e6705d5fcce90b9f583",
          "originalWidth": 400,
          "originalHeight": 170,
          "caption": "Logo (PRNewsfoto/Antengene Corporation Limited)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iX4d3zH6.489mYmi5zPGYg--~B/aD0xNzA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/80e76465ee715e6705d5fcce90b9f583.cf.webp",
              "width": 400,
              "height": 170,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/p3TrWaua._04_VbJue7uzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/80e76465ee715e6705d5fcce90b9f583.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/antengene-presents-jpm-strong-clinical-010000312.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/antengene-presents-jpm-strong-clinical-010000312.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "6996.HK"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T00:55:49+00:00",
    "headline": "Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference",
    "summary": "Bioventus (NASDAQ:BVS) executives outlined a multi-year turnaround story and a set of new growth priorities during a presentation and Q&A session hosted by J.P. Morgan healthcare analyst David Brumund. CEO Rob Claypoole and CFO Mark Singleton emphasized recent margin and cash flow improvements,",
    "url": "https://www.marketbeat.com/instant-alerts/bioventus-details-turnaround-plan-four-growth-drivers-at-jp-morgan-conference-2026-01-15/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "29d3fc04-329b-36b3-a8ce-7c153524e359",
      "content": {
        "id": "29d3fc04-329b-36b3-a8ce-7c153524e359",
        "contentType": "STORY",
        "title": "Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference",
        "description": "",
        "summary": "Bioventus (NASDAQ:BVS) executives outlined a multi-year turnaround story and a set of new growth priorities during a presentation and Q&A session hosted by J.P. Morgan healthcare analyst David Brumund. CEO Rob Claypoole and CFO Mark Singleton emphasized recent margin and cash flow improvements,",
        "pubDate": "2026-01-16T00:55:49Z",
        "displayTime": "2026-01-16T00:55:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/2c5ba8e5cc51cf9a63ff65b609a5c083",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Bioventus logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N259AWQ6U4wqRJyP0RqcBQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/2c5ba8e5cc51cf9a63ff65b609a5c083.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lzg2IRcuf7d3JtHrmAgmSg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/2c5ba8e5cc51cf9a63ff65b609a5c083.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/bioventus-details-turnaround-plan-four-growth-drivers-at-jp-morgan-conference-2026-01-15/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bioventus-details-turnaround-plan-four-005549389.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BVS"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T03:15:53+00:00",
    "headline": "Why ORIC Pharmaceuticals (ORIC) Is Up 36.3% After New Cancer Data And Analyst Buzz",
    "summary": "ORIC Pharmaceuticals recently drew investor attention with positive analyst commentary, new clinical data on its lead oncology candidates, and a high-profile presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Promising efficacy signals for ORIC-944 in metastatic castration-resistant prostate cancer and a collaboration evaluating enozertinib with Johnson & Johnson’s amivantamab have strengthened confidence in the company’s late-stage cancer pipeline. We’ll now...",
    "url": "https://finance.yahoo.com/news/why-oric-pharmaceuticals-oric-36-031553983.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bcd9de05-aef9-38cf-b319-2387897ab0ad",
      "content": {
        "id": "bcd9de05-aef9-38cf-b319-2387897ab0ad",
        "contentType": "STORY",
        "title": "Why ORIC Pharmaceuticals (ORIC) Is Up 36.3% After New Cancer Data And Analyst Buzz",
        "description": "",
        "summary": "ORIC Pharmaceuticals recently drew investor attention with positive analyst commentary, new clinical data on its lead oncology candidates, and a high-profile presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Promising efficacy signals for ORIC-944 in metastatic castration-resistant prostate cancer and a collaboration evaluating enozertinib with Johnson & Johnson’s amivantamab have strengthened confidence in the company’s late-stage cancer pipeline. We’ll now...",
        "pubDate": "2026-01-16T03:15:53Z",
        "displayTime": "2026-01-16T03:15:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I2k3PKJsWIEX9xgEQz8JwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmSjpFKmBAT61w1lG5.BLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-oric-pharmaceuticals-oric-36-031553983.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-oric-pharmaceuticals-oric-36-031553983.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ORIC"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T08:07:08+00:00",
    "headline": "Best savings account deals that offer above-inflation rates",
    "summary": "Check the best savings accounts to find a top-rated deal that works for you.",
    "url": "https://uk.finance.yahoo.com/news/best-savings-accounts-deals-inflation-rates-130148742.html",
    "source": "Yahoo Finance UK",
    "provider": "yfinance",
    "raw": {
      "id": "ef17bbd9-c32a-4aa7-a694-2847b774e131",
      "content": {
        "id": "ef17bbd9-c32a-4aa7-a694-2847b774e131",
        "contentType": "STORY",
        "title": "Best savings account deals that offer above-inflation rates",
        "description": "",
        "summary": "Check the best savings accounts to find a top-rated deal that works for you.",
        "pubDate": "2026-01-16T08:07:08Z",
        "displayTime": "2026-01-16T08:07:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/c4098550-ed45-11f0-a7e7-fc3b56a64e15",
          "originalWidth": 6016,
          "originalHeight": 4003,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AD0j7nWtdf0wJk_ByGH7GQ--~B/aD00MDAzO3c9NjAxNjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/c4098550-ed45-11f0-a7e7-fc3b56a64e15.cf.webp",
              "width": 6016,
              "height": 4003,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8P_RmelKwFT.WRlvG.oB5w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/c4098550-ed45-11f0-a7e7-fc3b56a64e15.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance UK",
          "url": "http://uk.finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/best-savings-accounts-deals-inflation-rates-130148742.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-savings-accounts-deals-inflation-rates-130148742.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SAN.MC"
            },
            {
              "symbol": "^FTSE"
            },
            {
              "symbol": "GBPEUR=X"
            },
            {
              "symbol": "GBP=X"
            },
            {
              "symbol": "EUR=X"
            },
            {
              "symbol": "NWG"
            },
            {
              "symbol": "TSCDF"
            },
            {
              "symbol": "TSCDY"
            },
            {
              "symbol": "GBPUSD=X"
            },
            {
              "symbol": "USD=X"
            },
            {
              "symbol": "GBP=X"
            },
            {
              "symbol": "BCS"
            },
            {
              "symbol": "NBS.L"
            },
            {
              "symbol": "SAN"
            },
            {
              "symbol": "GS"
            },
            {
              "symbol": "TSCO.L"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T12:30:43+00:00",
    "headline": "JPM26: Medtech CEO says conference’s appeal in decline",
    "summary": "The limited time to ‘get things done’ and the high cost of attending the J.P. Morgan conference are factors that are beginning to dampen its appeal.",
    "url": "https://www.medicaldevice-network.com/news/jpm26-medtech-ceo-says-conference-appeal-in-decline/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "5788a5bb-21d2-3001-8be2-bbf2d99c4acc",
      "content": {
        "id": "5788a5bb-21d2-3001-8be2-bbf2d99c4acc",
        "contentType": "STORY",
        "title": "JPM26: Medtech CEO says conference’s appeal in decline",
        "description": "",
        "summary": "The limited time to ‘get things done’ and the high cost of attending the J.P. Morgan conference are factors that are beginning to dampen its appeal.",
        "pubDate": "2026-01-16T12:30:43Z",
        "displayTime": "2026-01-16T12:30:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/078dec82cc049003a1f28c0fb5cbd967",
          "originalWidth": 1440,
          "originalHeight": 960,
          "caption": "According to Dave Rosa",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m07wfKBZwPGeD64_Tse.JA--~B/aD05NjA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/078dec82cc049003a1f28c0fb5cbd967.cf.webp",
              "width": 1440,
              "height": 960,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u0sNvhdynbpjph0I5cc00A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/078dec82cc049003a1f28c0fb5cbd967.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/jpm26-medtech-ceo-says-conference-appeal-in-decline/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-medtech-ceo-says-conference-123043704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "SYK"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T10:30:00+00:00",
    "headline": "Wall Street Is Split on Stock Market’s Top-Performing Sector",
    "summary": "Energy has been the best-performing sector in the S&P 500 Index in the past three months, following crude prices higher as the Trump administration pursued a takeover of Venezuela’s oil industry and threatened to intervene in deadly protests in Iran.  Walter Todd, chief investment officer at Greenwood Capital Associates, said his firm is overweight the sector and sees it as “offering an attractive risk-reward at these levels, particularly versus areas of the market that have already run aggressively over the past year.”",
    "url": "https://finance.yahoo.com/news/wall-street-split-stock-market-103000496.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "23b0f447-4a31-3f49-b328-de8b5f290257",
      "content": {
        "id": "23b0f447-4a31-3f49-b328-de8b5f290257",
        "contentType": "STORY",
        "title": "Wall Street Is Split on Stock Market’s Top-Performing Sector",
        "description": "",
        "summary": "Energy has been the best-performing sector in the S&P 500 Index in the past three months, following crude prices higher as the Trump administration pursued a takeover of Venezuela’s oil industry and threatened to intervene in deadly protests in Iran.  Walter Todd, chief investment officer at Greenwood Capital Associates, said his firm is overweight the sector and sees it as “offering an attractive risk-reward at these levels, particularly versus areas of the market that have already run aggressively over the past year.”",
        "pubDate": "2026-01-16T10:30:00Z",
        "displayTime": "2026-01-16T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/5140efe6db0d9c335ff84aa6e779a96c",
          "originalWidth": 389,
          "originalHeight": 275,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Nwe4AoSwrnxvLFwiYmDhxg--~B/aD0yNzU7dz0zODk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/5140efe6db0d9c335ff84aa6e779a96c.cf.webp",
              "width": 389,
              "height": 275,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wKVb6fZfyvvZH_iGyjnTrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/5140efe6db0d9c335ff84aa6e779a96c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-split-stock-market-103000496.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-split-stock-market-103000496.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "GS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T07:22:57+00:00",
    "headline": "The clinical candidates pharma execs are tracking",
    "summary": "Industry leaders at JPM this week revealed which up-and-coming assets they’re watching from other companies in oncology and neuroscience.",
    "url": "https://www.pharmavoice.com/news/pharma-drug-readout-jpm-merck-summit-takeda-cancer/809807/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "d014d8f9-0bc4-3c6d-a206-5ed55cafe2ea",
      "content": {
        "id": "d014d8f9-0bc4-3c6d-a206-5ed55cafe2ea",
        "contentType": "STORY",
        "title": "The clinical candidates pharma execs are tracking",
        "description": "",
        "summary": "Industry leaders at JPM this week revealed which up-and-coming assets they’re watching from other companies in oncology and neuroscience.",
        "pubDate": "2026-01-16T07:22:57Z",
        "displayTime": "2026-01-16T07:22:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/943a12d98e3f21d97f1a4fef388ac3b0",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eRkPAe6uzFymkayFLaUg7Q--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/943a12d98e3f21d97f1a4fef388ac3b0.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a7n7Bu00IJTGbJbqcmHK3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/943a12d98e3f21d97f1a4fef388ac3b0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/pharma-drug-readout-jpm-merck-summit-takeda-cancer/809807/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/clinical-candidates-pharma-execs-tracking-072257352.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "ONPH"
            },
            {
              "symbol": "ILMN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T13:31:50+00:00",
    "headline": "Earnings live: PNC stock pops after bank beats estimates, State Street and J.B. Hunt shares slide",
    "summary": "Results from Delta Air Lines and JPMorgan this week got fourth quarter earnings season underway.",
    "url": "https://finance.yahoo.com/news/live/earnings-live-pnc-stock-pops-after-bank-beats-estimates-state-street-and-jb-hunt-shares-slide-133134704.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "19cd1080-a43d-4393-8ed1-77d2b30d3322",
      "content": {
        "id": "19cd1080-a43d-4393-8ed1-77d2b30d3322",
        "contentType": "STORY",
        "title": "Earnings live: PNC stock pops after bank beats estimates, State Street and J.B. Hunt shares slide",
        "description": "",
        "summary": "Results from Delta Air Lines and JPMorgan this week got fourth quarter earnings season underway.",
        "pubDate": "2026-01-16T13:31:50Z",
        "displayTime": "2026-01-16T13:31:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/5fb60ac0-f2df-11f0-bf9b-c8c2f4e323f7",
          "originalWidth": 8152,
          "originalHeight": 5435,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRjKYYJwEsUr6r9EzMB0TQ--~B/aD01NDM1O3c9ODE1MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/5fb60ac0-f2df-11f0-bf9b-c8c2f4e323f7.cf.webp",
              "width": 8152,
              "height": 5435,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LAWXyuT8jpG3l5rB8QAKeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/5fb60ac0-f2df-11f0-bf9b-c8c2f4e323f7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-pnc-stock-pops-after-bank-beats-estimates-state-street-and-jb-hunt-shares-slide-133134704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-pnc-stock-pops-after-bank-beats-estimates-state-street-and-jb-hunt-shares-slide-133134704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DAL"
            },
            {
              "symbol": "WFC"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "BAC"
            },
            {
              "symbol": "BLK"
            },
            {
              "symbol": "GS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T12:03:00+00:00",
    "headline": "JPMorgan Forms New Team to Get In on the Boom in Private Markets",
    "summary": "While IPOs are expected to rise this year, the bank is betting on a structural shift in how companies raise capital.",
    "url": "https://www.wsj.com/finance/banking/jpmorgan-forms-new-team-to-get-in-on-the-boom-in-private-markets-f1f2f67c",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "481721e1-d960-3f84-aa34-85ddf6464ea4",
      "content": {
        "id": "481721e1-d960-3f84-aa34-85ddf6464ea4",
        "contentType": "STORY",
        "title": "JPMorgan Forms New Team to Get In on the Boom in Private Markets",
        "description": "",
        "summary": "While IPOs are expected to rise this year, the bank is betting on a structural shift in how companies raise capital.",
        "pubDate": "2026-01-16T12:03:00Z",
        "displayTime": "2026-01-16T12:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_wall_street_journal_hosted_996/2c0c4fe7bec9684befa258b1501c8541",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cqh5HXoDToTJcmQqhyQ5qw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_wall_street_journal_hosted_996/2c0c4fe7bec9684befa258b1501c8541.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j4DlZLUSyVl0we7mruIXfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_wall_street_journal_hosted_996/2c0c4fe7bec9684befa258b1501c8541.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/finance/banking/jpmorgan-forms-new-team-to-get-in-on-the-boom-in-private-markets-f1f2f67c",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-forms-team-boom-private-120300761.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T14:00:14+00:00",
    "headline": "JPMorgan Chase's (NYSE:JPM) three-year total shareholder returns outpace the underlying earnings growth",
    "summary": "It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...",
    "url": "https://finance.yahoo.com/news/jpmorgan-chases-nyse-jpm-three-140014657.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "573c1ecf-8593-31b1-9b0d-9f0cbd895fc3",
      "content": {
        "id": "573c1ecf-8593-31b1-9b0d-9f0cbd895fc3",
        "contentType": "STORY",
        "title": "JPMorgan Chase's (NYSE:JPM) three-year total shareholder returns outpace the underlying earnings growth",
        "description": "",
        "summary": "It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...",
        "pubDate": "2026-01-16T14:00:14Z",
        "displayTime": "2026-01-16T14:00:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/buiFSDj_0ot5Q6v9J14wWA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jnehXQ3eKjDwH262Ddswdg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/1476b1d98076b29c1959b169006c1fee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-chases-nyse-jpm-three-140014657.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-chases-nyse-jpm-three-140014657.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T13:38:52+00:00",
    "headline": "Jamie Dimon Rules Out Fed Chair, Says He'd Take Treasury Call",
    "summary": "The JPMorgan CEO rejects the Fed role and comments on central bank independence amid a public exchange with President Donald Trump.",
    "url": "https://finance.yahoo.com/news/jamie-dimon-rules-fed-chair-133852140.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "e1886649-a5f8-35cb-9f74-8a55e84ee106",
      "content": {
        "id": "e1886649-a5f8-35cb-9f74-8a55e84ee106",
        "contentType": "STORY",
        "title": "Jamie Dimon Rules Out Fed Chair, Says He'd Take Treasury Call",
        "description": "",
        "summary": "The JPMorgan CEO rejects the Fed role and comments on central bank independence amid a public exchange with President Donald Trump.",
        "pubDate": "2026-01-16T13:38:52Z",
        "displayTime": "2026-01-16T13:38:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/610c1c2a168b5b8fa5a2773241982f60",
          "originalWidth": 700,
          "originalHeight": 394,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bSnY.sLcm7qSp817i9RTRA--~B/aD0zOTQ7dz03MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/610c1c2a168b5b8fa5a2773241982f60.cf.webp",
              "width": 700,
              "height": 394,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xOmnQVyHLrrNZL6jQQx9Rw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/610c1c2a168b5b8fa5a2773241982f60.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jamie-dimon-rules-fed-chair-133852140.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jamie-dimon-rules-fed-chair-133852140.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T14:51:12+00:00",
    "headline": "Market Story for This Year Is About Broadening, JPMorgan's Parker Says",
    "summary": "The broadening of the market \"has legs in the year ahead,\" says Stephen Parker, co-head of global investment strategy at JPMorgan Private Bank, as he expects to see a cyclical recovery that is not predicated on rate cuts.",
    "url": "https://finance.yahoo.com/video/market-story-broadening-jpmorgans-parker-145112399.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "2ac397ca-2359-314d-b3c4-425eadd801aa",
      "content": {
        "id": "2ac397ca-2359-314d-b3c4-425eadd801aa",
        "contentType": "VIDEO",
        "title": "Market Story for This Year Is About Broadening, JPMorgan's Parker Says",
        "description": "The broadening of the market \"has legs in the year ahead,\" says Stephen Parker, co-head of global investment strategy at JPMorgan Private Bank, as he expects to see a cyclical recovery that is not predicated on rate cuts.",
        "summary": "The broadening of the market \"has legs in the year ahead,\" says Stephen Parker, co-head of global investment strategy at JPMorgan Private Bank, as he expects to see a cyclical recovery that is not predicated on rate cuts.",
        "pubDate": "2026-01-16T14:51:12Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_markets_video_2/3b1f71a27061d5b667453d622bdca9f9",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1gFhBm1A0Ic3u0EDorIYrg--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_video_2/3b1f71a27061d5b667453d622bdca9f9.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZgkmDifqBZ.WqTL_TqIDXA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_markets_video_2/3b1f71a27061d5b667453d622bdca9f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/market-story-broadening-jpmorgans-parker-145112399.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/market-story-broadening-jpmorgans-parker-145112399.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-16T14:41:15+00:00",
    "headline": "Honeywell upgraded at JPM as breakup nears and aerospace momentum builds",
    "summary": "Investing.com -- JPMorgan upgraded Honeywell to Overweight, saying the stock’s discount to its sum-of-the-parts valuation and improving underlying momentum create an opportunity ahead of the planned breakup.",
    "url": "https://finance.yahoo.com/news/honeywell-upgraded-jpm-breakup-nears-144115373.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "b7091093-1a0d-3d0b-8e4f-c770ba8f1d25",
      "content": {
        "id": "b7091093-1a0d-3d0b-8e4f-c770ba8f1d25",
        "contentType": "STORY",
        "title": "Honeywell upgraded at JPM as breakup nears and aerospace momentum builds",
        "description": "",
        "summary": "Investing.com -- JPMorgan upgraded Honeywell to Overweight, saying the stock’s discount to its sum-of-the-parts valuation and improving underlying momentum create an opportunity ahead of the planned breakup.",
        "pubDate": "2026-01-16T14:41:15Z",
        "displayTime": "2026-01-16T14:41:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/honeywell-upgraded-jpm-breakup-nears-144115373.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/honeywell-upgraded-jpm-breakup-nears-144115373.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "HON"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]